Economic evaluation of adding dapagliflozin to standard care in the treatment of chronic kidney disease: a systematic review
{{output}}
Introduction: Chronic kidney disease is a significant public health issue. Dapagliflozin has been shown to improve the quality of life for patients with chronic kidney disease. This review aimed to systematically assess the cost-... ...
